Leanne Kelly
Director of Finance/CFO chez GRI BIO, INC.
Fortune : 22 $ au 31/03/2024
Profil
Leanne M.
Kelly is a professional with experience in finance and accounting.
Currently, she holds two positions, one as a Member at the Pennsylvania Institute of Certified Public Accountants and the other as Chief Financial Officer at GRI Bio, Inc. In the past, she has worked as a Chief Financial Officer, Secretary & SVP at Genaera Corp., an Accountant at Luminant Worldwide Corp., a Controller at OptiNose, Inc., a Senior Vice President-Finance at Flower Orthopedics Corp., a Senior Auditor at KPMG LLP, a Controller at Lamina Ceramics, Inc., a Controller at Iroko Pharmaceuticals LLC, and a Chief Financial & Accounting Officer at Vallon Pharmaceuticals, Inc. She received her undergraduate degree from Lehigh University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GRI BIO, INC.
0,00% | 31/12/2023 | 29 ( 0,00% ) | 22 $ | 31/03/2024 |
Postes actifs de Leanne Kelly
| Sociétés | Poste | Début |
|---|---|---|
| GRI BIO, INC. | Director of Finance/CFO | 25/04/2023 |
Pennsylvania Institute of Certified Public Accountants
 Pennsylvania Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The Pennsylvania Institute of Certified Public Accountants is a professional association for certified public accountants operating statewide. The non-profit company is based in Pennsylvania. | Corporate Officer/Principal | - |
Anciens postes connus de Leanne Kelly
| Sociétés | Poste | Fin |
|---|---|---|
| OPTINOSE, INC. | Comptroller/Controller/Auditor | 01/05/2021 |
Genaera Corp.
 Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Director of Finance/CFO | 13/07/2009 |
Lamina Ceramics, Inc.
 Lamina Ceramics, Inc. Electronic Production EquipmentElectronic Technology Lamina Ceramics, Inc. develops and manufactures super-bright LED light engines. The company's LED packaging technology & design and its proprietary multi-layer ceramic on metal packaging solution provides thermal management and interconnectivity. The company was founded in 2001 and is headquartered in Westampton, NJ. | Comptroller/Controller/Auditor | 01/12/2002 |
Luminant Worldwide Corp.
 Luminant Worldwide Corp. Internet Software/ServicesTechnology Services Luminant Worldwide Corp. provides Internet and electronic commerce professional services. It services include, strategy consulting, creative solutions, technology solutions and ongoing services. The company was founded in August 1998 and is headquartered in Houston, TX. | Comptroller/Controller/Auditor | 01/11/2001 |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | 01/03/2000 |
Formation de Leanne Kelly
| Lehigh University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OPTINOSE, INC. | Health Technology |
| Entreprise privées | 9 |
|---|---|
Genaera Corp.
Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Health Technology |
Luminant Worldwide Corp.
Luminant Worldwide Corp. Internet Software/ServicesTechnology Services Luminant Worldwide Corp. provides Internet and electronic commerce professional services. It services include, strategy consulting, creative solutions, technology solutions and ongoing services. The company was founded in August 1998 and is headquartered in Houston, TX. | Technology Services |
Flower Orthopedics Corp.
 Flower Orthopedics Corp. Medical SpecialtiesHealth Technology Flower Orthopedics Corp. engages in the provision of bone-fixation implants. Its products include plates, trials, cannulated and headless compressions screws, plating screws, washers, instrument kits, drill bit, flower biologics, and ancillary instruments. The company was founded by Oliver Burckhardt in June 2012 and is headquartered in Horsham, PA. | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |
Lamina Ceramics, Inc.
Lamina Ceramics, Inc. Electronic Production EquipmentElectronic Technology Lamina Ceramics, Inc. develops and manufactures super-bright LED light engines. The company's LED packaging technology & design and its proprietary multi-layer ceramic on metal packaging solution provides thermal management and interconnectivity. The company was founded in 2001 and is headquartered in Westampton, NJ. | Electronic Technology |
Pennsylvania Institute of Certified Public Accountants
Pennsylvania Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The Pennsylvania Institute of Certified Public Accountants is a professional association for certified public accountants operating statewide. The non-profit company is based in Pennsylvania. | Commercial Services |
Iroko Pharmaceuticals LLC
 Iroko Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Iroko Pharmaceuticals LLC develops and distributes pharmaceutical products. It provides approved US products, marketed global, medical information and product patents. The company was founded in 2007 and is headquartered in Philadelphia, PA. | Health Technology |
Vallon Pharmaceuticals, Inc.
 Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vallon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on the development and commercialization of proprietary biopharmaceutical products. The firm's primary product is Abuse-Deterrent Amphetamine Immediate and its product pipeline includes ADAIR, ADMIR, ADHD, and Narcolepsy. The company was founded by David C. Baker on January 11, 2018 and is headquartered in Philadelphia, PA. | Health Technology |
| GRI Bio, Inc. |
